European Expert Consortium to Develop a Novel Pandemic Flu Vaccine - - BioPharm International

ADVERTISEMENT

European Expert Consortium to Develop a Novel Pandemic Flu Vaccine

BioPharm Bulletin

Five European organizations, including three companies and two hospitals, have joined forces to develop a novel pandemic influenza vaccine as a potential emergency vaccination.

The four-year FluVac project, as it will be called, has been awarded a grant of €3.5 million from the European Union to help fund the research and the development of a new vaccine. Nobilon International BV will coordinate the project. The FluVac project consortium consists of Nobilon International BV (Boxmeer, the Netherlands), Protherics PLC (Cheshire, UK), Retroscreen Virology Ltd (London, UK), Erasmus Medical Centre (Rotterdam, the Netherlands), and Landspitali University Hospital (Reykjavik, Iceland).

Nobilon release

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Lundbeck CEO Resigns Due to Code of Conduct Breach
November 24, 2014
GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
Author Guidelines
Source: BioPharm Bulletin,
Click here